Antithrombotic regimens and need for critical care interventions among patients with subdural hematomas.

ABSTRACT:

Background

Antithrombotic-associated subdural hematomas (SDHs) are increasingly common, and the possibility of clinical deterioration in otherwise stable antithrombotic-associated SDH patients may prompt unnecessary admissions to intensive care units. It is unknown whether all antithrombotic regimens are equally associated with the need for critical care interventions. We sought to compare the frequency of critical care interventions and poor functional outcomes among three cohorts of noncomatose SDH patients: patients on no antithrombotics, patients on anticoagulants, and patients on antiplatelets alone.

Methods

We performed a retrospective cohort study on all noncomatose SDH patients (Glasgow Coma Scale > 12) presenting to an academic health system in 2018. The three group

SUBMITTER: Robinson D 

PROVIDER: S-EPMC9069411 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature